$8.58
0.040.47%
Pre-Market: 5:45 PM EDT
15 minutes delayed
Comments
Loading...
INmune Bio
INMBNASDAQ
INmune Bio (NASDAQ:INMB) Stock, Earnings Estimates, EPS, And Revenue
INmune Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 5
EPS Estimate
$-0.630
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$131K
Analyze the earnings history of INmune Bio using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INMB | INmune Bio | -$0.36 | -$0.63 | — | — | $46.00K | — | — | — | 08/05/2024 | Get Alert |
| INMB | INmune Bio | -$0.36 | -$0.53 | -$0.61 | -15.09% | $38.00K | $30.00K | $14.00K | -53.33% | 05/09/2024 | Get Alert |
| INMB | INmune Bio | -$0.32 | -$0.44 | -$0.47 | -6.82% | $97.00K | $40.00K | $28.00K | -30.00% | 03/28/2024 | Get Alert |
| INMB | INmune Bio | -$0.43 | -$0.41 | -$0.48 | -17.07% | $98.00K | — | $43.00K | — | 11/01/2023 | Get Alert |
| INMB | INmune Bio | -$0.38 | -$0.40 | -$0.36 | 10.00% | $16.00K | — | $46.00K | — | 08/07/2023 | Get Alert |
| INMB | INmune Bio | -$0.39 | -$0.02 | -$0.36 | -1700.00% | $163.00K | — | $38.00K | — | 05/03/2023 | Get Alert |
| INMB | INmune Bio | -$0.55 | -$0.48 | -$0.32 | 33.33% | $163.00K | — | $97.00K | — | 03/02/2023 | Get Alert |
| INMB | INmune Bio | -$0.55 | -$0.52 | -$0.43 | 17.31% | $14.00K | — | $98.00K | — | 11/02/2022 | Get Alert |
| INMB | INmune Bio | -$0.44 | -$0.50 | -$0.38 | 24.00% | $0.00 | — | $16.00K | — | 08/03/2022 | Get Alert |
| INMB | INmune Bio | -$0.32 | -$0.64 | -$0.39 | 39.06% | $4.00K | — | $163.00K | — | 05/05/2022 | Get Alert |
| INMB | INmune Bio | -$0.24 | -$0.58 | -$0.55 | 5.17% | $10.92K | — | $163.00K | — | 03/03/2022 | Get Alert |
| INMB | INmune Bio | -$0.36 | -$0.38 | -$0.55 | -44.74% | $0.00 | $970.00K | $14.00K | -98.56% | 11/03/2021 | Get Alert |
| INMB | INmune Bio | -$0.20 | -$0.34 | -$0.44 | -29.41% | $0.00 | — | $0.00 | — | 08/04/2021 | Get Alert |
| INMB | INmune Bio | -$0.19 | -$0.27 | -$0.32 | -18.52% | $0.00 | — | $4.00K | — | 05/05/2021 | Get Alert |
| INMB | INmune Bio | -$0.22 | — | -$0.24 | — | $0.00 | — | $10.92K | — | 03/04/2021 | Get Alert |
| INMB | INmune Bio | -$0.28 | -$0.17 | -$0.36 | -111.76% | $0.00 | — | $0.00 | — | 11/05/2020 | Get Alert |
| INMB | INmune Bio | -$0.04 | -$0.20 | -$0.20 | 0.00% | $0.00 | — | $0.00 | — | 08/05/2020 | Get Alert |
| INMB | INmune Bio | -$0.20 | -$0.21 | -$0.19 | 9.52% | $0.00 | — | $0.00 | — | 05/14/2020 | Get Alert |
| INMB | INmune Bio | — | -$0.25 | -$0.22 | 12.00% | — | — | $0.00 | — | 03/11/2020 | Get Alert |
| INMB | INmune Bio | -$0.18 | -$0.19 | -$0.28 | -47.37% | — | — | $0.00 | — | 11/08/2019 | Get Alert |
| INMB | INmune Bio | -$0.71 | -$0.19 | -$0.19 | 0.00% | — | $80.00K | $0.00 | -100.00% | 08/12/2019 | Get Alert |
INmune Bio (INMB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.61 | $-0.53 | -15.1 % |
| Dec 2023 | 2024-03-28 | $-0.47 | $-0.44 | -6.82 % |
| Sep 2023 | 2023-11-01 | $-0.48 | $-0.41 | -17.1 % |
| Jun 2023 | 2023-08-07 | $-0.36 | $-0.40 | 10.0 % |
INmune Bio (INMB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $14.00K | $30.00K | -53.3 % |
| Dec 2023 | 2024-03-28 | $28.00K | $40.00K | -30.0 % |
| Sep 2021 | 2021-11-03 | $14.00K | $970.00K | -98.6 % |
| Jun 2019 | 2019-08-12 | $0 | $80.00K | -100.0 % |
FAQ
When is INmune Bio (NASDAQ:INMB) reporting earnings?
INmune Bio (INMB) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for INmune Bio (NASDAQ:INMB)?
The Actual EPS was $-0.61, which missed the estimate of $-0.53.
What were INmune Bio’s (NASDAQ:INMB) revenues?
The Actual Revenue was $14K, which missed the estimate of $30K.
Browse earnings estimates, EPS, and revenue on all stocks.